Alliance Pharma delays preliminary results
22nd Apr 2024 10:03
(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.
Read moreAlliance Pharma to delay release of 2023 results
5th Apr 2024 07:39
(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.
Read moreAlliance Pharma names Camillo Pane as chair
5th Feb 2024 09:07
(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth through marketing and innovation.
Read moreRBC Capital Markets nudges down Alliance Pharma price target
31st Jan 2024 10:34
(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its forecasts as trading normalises.
Read moreAlliance Pharma expects no profit growth in 2024
29th Jan 2024 10:51
(Sharecast News) - Consumer healthcare group Alliance Pharma has said that 2023 results will be in line with market expectations but said that profits are unlikely to grow this year due to increased investment in sales and marketing.
Read moreAlliance Pharma confident after some first-half setbacks
26th Sep 2023 10:16
(Sharecast News) - Consumer healthcare firm Alliance Pharma reported first-half revenue growth for its Kelo-Cote and Nizoral products on Tuesday, meeting the board's expectations.
Read moreAlliance Pharma reports resilient first-half trading
18th Jul 2023 10:00
(Sharecast News) - Alliance Pharma reported see-through revenues of £82.4m in a first-half trading update on Tuesday, representing a 1.1% increase year-on-year.
Read moreCurrency headwinds to impact Alliance Pharma profits
25th May 2023 15:06
(Sharecast News) - Consumer healthcare company Alliance Pharma said in an update on Thursday that sales for the first four months of the year were ahead of the equivalent period in 2022, although it warned that currency headwinds looked set to impact full-year profits.
Read moreAlliance Pharma confident despite weak results
21st Mar 2023 14:57
(Sharecast News) - International healthcare company Alliance Pharma reported a trading performance that fell short of its initial expectations in its preliminary results on Tuesday.
Read moreAlliance Pharma ends year in line with recent forecasts
17th Jan 2023 17:11
(Sharecast News) - Alliance Pharma said in a trading update on Tuesday that it delivered see-through revenues of £172m in 2022, up from £169.6m in 2021 and in line with its November trading update.
Read moreAlliance Pharma adds operations chief to management team
12th Jan 2023 12:19
(Sharecast News) - Alliance Pharma announced the appointment of a chief operating officer on Thursday, in a bid to strengthen its executive team and board of directors, and to support the delivery of its growth strategy focussed on consumer health.
Read moreAlliance Pharma tumbles amid slower market recovery
23rd Nov 2022 13:15
(Sharecast News) - Alliance Pharma updated the market on fourth quarter trading on Wednesday, reporting that the expected recovery in some of its demand was happening more slowly than anticipated.
Read moreAlliance Pharma revenue rises, profits narrow in first half
20th Sep 2022 09:54
(Sharecast News) - Alliance Pharma reported see-through revenue of £81.6m in its first half on Tuesday, up slightly from the £80.9m it recorded a year ago, while its statutory revenue improved to £78.8m from £78.6m.
Read moreAlliance Pharma appeals competition disqualification order
2nd Sep 2022 08:13
(Sharecast News) - Healthcare group Alliance Pharma has launched an appeal against a competition disqualification order levelled against a total of seven directors by the Competition and Markets Authority.
Read moreAlliance Pharma shares slide following challenging H1
20th Jul 2022 10:07
(Sharecast News) - Healthcare outfit Alliance Pharma reiterated full-year guidance on Wednesday as it said challenges faced in the first half were expected to ease in the second.
Read more